August 1, 2018 MJ Shareholders
August 1st, 2018
Exclusive, News, Top News
Pure Global Cannabis Inc. (TSXV:PURE) (OTC: PRCNF) is launching Canada’s first multi-ponic cannabis farm – a patent-pending system that is expected to produce several fold greater yields over traditional methods while reducing cost and eliminating pesticide and herbicide use.
Utilizing leading-edge pharmaceutical technologies, the company’s vision is to harness the therapeutic properties of cannabis to produce world-class products for the medical, wellness, and adult-use markets. Pure Global Cannabis is currently in Phase 1 of its facility development plan and has obtained sufficient resources to fund development and operations through Phase 4.
Phases of Development
Pure Global’s Phase 1 objectives are to obtain its Canadian sales license and to secure sufficient product from other quality producers to develop extraction methods and to package new and innovative brands and products. To that end, Pure Global has recently announced that the company’s wholly owned subsidiary, PureSinse Inc., has signed agreements with the Supreme Cannabis Company Inc. and two other ACMPR Licensed Producers, to obtain premium quality medical cannabis to meet the high-quality standards of the PURE brand. Pure Global President and CEO, Malay Panchal stated, “Procuring adequate supply of quality cannabis is an important milestone for PURE as we approach our full market launch for serving medical cannabis patients across Canada within the next several months. We will continue to work with Supreme and several other premium quality ACMPR producers to execute Phase I of our business model to initiate revenue generation.”
The Phase 1 facility is comprised of a Level 9 vault, a lab that focuses on extraction and microbiology, and order processing, packaging, and shipping capabilities. Pure Global received its ACMPR license to cultivate in December 2017, without any cultivation capacity at the time. The uncommon strategy helped the company derisk its application to some extent by limiting the capital expenditure for a cultivation facility, while allowing the company to focus on capabilities that can more immediately impact revenue generation upon receipt of a sales license. Phase 1 is projected to be completed imminently.
Phase 2 will involve implementing an 18,000 square foot cultivation facility able to produce 4,000 kg/year. Phase 2 will also implement multiple tiers of vertical farming cultivation and a state-of-the-art multi-ponic system to create a soil-less, pesticide-free environment. This patent-pending hybrid system delivers a degree of automation in a closed-loop nutrient delivery system, which allows tailoring of the biochemistry and nutrients to deliver exactly what the roots need at every stage for optimal growth. Additionally, the vertical grow system enables growing multiple tiers of canopy, exponentially increasing potential yield 3 or 4 times the production from the same square footage without herbicides or pesticides. The drying, trimming, processing, extractions, and packaging processes will also be implemented during Phase 2, which is scheduled to be completed within the fourth quarter of 2018.
Phases 3 & 4 will include the building of an adjacent 23,000 square foot vertical farming cultivation and processing facility capable of producing 8,000 kg/year. This facility will include an extraction, distillation lab, an advanced analytical R&D laboratory, and will look to commercialize finished product at scale. These phases are slated for completion during the first quarter of 2019.
The Way Forward
On the customer acquisition front, Pure Global is strategically partnering with cannabis clinics, referring physicians, and one of the largest medical groups in Canada, which has an electronic database of millions of patients. This with an innovative marketing strategy that opens new patient touch points across various customer verticals will ensure the growth of market share for sustained success.
Pure Global is positioning itself to obtain Good Manufacturing Practice (GMP) and ISO certifications for Canadian markets and for export of its products eligible for worldwide markets. Such a certification of the company’s facilities and processes is essential to achieve its goal of expanding commercial operations to South America, Europe, Australia, and Asia.
PURE is preparing for the upcoming legalization of cannabis for adult use nationwide in Canada. Rather than focus on just recreational use, the company will put its emphasis more on the wellness aspect, providing unique pharmaceutical, nutraceutical, food & beverage, beauty, and topical value-added cannabis products. These products lend themselves to brand development and offer the possibilities of higher margins, which will be especially important as the cannabis industry matures and cannabis flower itself becomes more commoditized.
Pure Global has also recently applied for eligibility to the Depository Trust Company (“DTC”) for its share trading, as well as on the United States OTC market under the symbol “PRCNF”. The company expects to be fully DTC eligible in the coming weeks. Combined, these moves would make it much easier for US investors to buy the company’s stock and should help to expand its investor base. The company is also in the process of listing on Germany’s Frankfurt exchange in the coming weeks for broader capital markets exposure.
Pure Global Cannabis Inc. is a growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural and supply chain experts. The Pure Global portfolio will feature a wide spectrum of products, formulations, and infusions for both the medical and adult-use markets, at home and abroad.
For more information, visit the company’s website
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
About Wallace Grafton
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers